“…Furthermore, solvent residues and solvent evaporation may damage the structural integrity due to cracking and shrinkage of preparations [ 15 ]. Moreover, solvent evaporation maintains the volume of the formulation, which can easily create a loose microchannel structure unfavorable for the controlled release of water-soluble drugs [ 16 ]. Despite the challenges associated with DIW, its mild molding conditions have brought new processes to the pharmaceutical industry, necessitating solutions to accelerate the development and industrialization of DIW drug manufacturing technology.…”